Veteran actor Firdous Jamal opens up about his ban from Hum TV and shares his perspective on how some podcasters create controversy.
Veteran Pakistani television and film actor Firdous Jamal recently appeared on Ambreen Fatima’s YouTube show, where he candidly discussed his lifetime ban from Hum TV and the perceived ‘traps’ set by certain podcasters. His remarks have once again sparked debate within the entertainment industry regarding artistic freedom and media ethics.

Known for his impactful roles in dramas like Pyare Afzal, Khuda Aur Mohabbat, and Waris, Firdous Jamal has enjoyed a prolific career spanning decades. The senior actor, whose esteemed presence has graced numerous productions, often finds himself in the spotlight due to his outspoken nature in interviews. You can follow his journey and career updates via his official social media presence, though he does not maintain a public Instagram account for direct linking.

Addressing the ban by Hum TV, Jamal asserted, “If Hum TV has banned me, it’s their loss, not mine. Like, if you are refusing a selling product; it’s not the fault of the product. If Hum is not taking me in their dramas, it’s not my loss because earnings come from Allah.” He further elaborated on his perspective regarding podcasters, stating, “I was unaware of the fact that these podcasters dig into controversy. Honestly, I was clueless about it. Now I have started to understand their strategy; otherwise, I didn’t know what they were doing to me.” He highlighted his simple, truth-speaking nature, emphasizing his focus on craft over personality-based criticism.
Jamal concluded by noting his realization that podcasters often prioritize controversy over technical discussions about his craft, believing that sensationalism garners more attention and popularity among audiences. This candid discussion sheds light on the challenges faced by veteran artists navigating the modern media landscape. What are your thoughts on Firdous Jamal’s insights into the industry?
Discover more from Dailyinfotainment
Subscribe to get the latest posts sent to your email.
